Jump to content

Daratumumab: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

24 June 2024

21 June 2024

18 May 2024

7 April 2024

31 March 2024

13 January 2024

20 December 2023

12 December 2023

19 August 2023

15 July 2023

10 April 2023

28 November 2022

26 November 2022

4 August 2022

5 June 2022

22 April 2022

23 March 2022

13 March 2022

20 January 2022

18 January 2022

10 January 2022

3 January 2022

19 December 2021

12 December 2021

10 October 2021

26 August 2021

24 April 2021

16 March 2021

17 January 2021

3 January 2021

16 November 2020

4 November 2020

24 September 2020

7 September 2020

  • curprev 09:1009:10, 7 September 2020185.58.164.45 talk 16,856 bytes 0 →‎Side effects: Correction of "infection related reactions" to "injection related reactions" - the context makes it clear that "injection" was what was intended here, and injection-related (or infusion-related) reactions are indeed a side effect of daratumumab. undo
  • curprev 09:0809:08, 7 September 2020185.58.164.45 talk 16,856 bytes +33 →‎Side effects: Correction of "multiple melanoma" to "multiple myeloma" - these are different conditions. Softening of the original statement "typically leads to bacterial and viral infections" to "potentially increases the patient's susceptibility to bacterial and viral infections", since in fact the majority of patients on daratumumab don't get such infections. undo

19 August 2020

9 August 2020

8 August 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)